CHRN
CHRONOSCALE (CHRN) Extends $2M B. Riley Note, Clears Path to Sell Ekso Bionics
An amendment pushes the maturity of a $2 million secured note to November 12, 2026 and makes a sale of the Ekso Bionics unit a permitted disposition.
CHRN
Market-moving news on ChronoScale Holdings (NASDAQ: CHRN): filings, earnings, deals and other events, from REDFILED.